Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2007-03-22 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROUBAIX (59100), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA VIGNE : revenue, balance sheet and financial ratios
PHARMACIE DE LA VIGNE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROUBAIX (59100),
this company of category PME
shows in 2024 a net income positive of 218 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA VIGNE (SIREN 497796391)
Indicator
2024
2023
2022
2021
2019
2018
2017
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
217 703 €
117 927 €
271 071 €
269 181 €
148 443 €
150 938 €
116 969 €
155 562 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA VIGNE generates positive net income of 218 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 156 k€ -> 218 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
217 703 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
21.8%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.393%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA VIGNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2017
2018
2019
2021
2022
2023
2024
Debt ratio
28.051
16.783
4.789
6.28
24.009
41.425
30.968
21.8
Financial autonomy
68.504
71.814
84.25
78.199
69.199
60.292
61.359
68.393
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
21.82024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-5 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE LA VIGNE (21.80) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.39%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+7 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA VIGNE (68.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 136.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
136.1
Liquidity indicators evolution PHARMACIE DE LA VIGNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
104.918
98.203
85.602
114.965
179.635
193.901
108.682
136.1
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
136.12024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-19 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA VIGNE (136.10) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DE LA VIGNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA VIGNE is estimated at
3 039 294 €
(range 2 116 516€ - 4 546 958€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2116k€3039k€4546k€
3 039 294 €Range: 2 116 516€ - 4 546 958€
NAF 5 année 2024
Valuation method used
Net Income Multiple
217 703 €
×
14.0x
=3 039 295 €
Range: 2 116 517€ - 4 546 959€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA VIGNE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA VIGNE
What is the revenue of PHARMACIE DE LA VIGNE ?
The revenue of PHARMACIE DE LA VIGNE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA VIGNE profitable?
Yes, PHARMACIE DE LA VIGNE generated a net profit of 218 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA VIGNE ?
The headquarters of PHARMACIE DE LA VIGNE is located in ROUBAIX (59100), in the department Nord.
Where to find the tax return of PHARMACIE DE LA VIGNE ?
The tax return of PHARMACIE DE LA VIGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA VIGNE operate?
PHARMACIE DE LA VIGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart